PDS Biotechnology
$5.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.43 (-7.90%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours
Why Robinhood?
You can buy or sell PDSB and other stocks, options, and ETFs commission-free!
About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
CEO
Frank K. Bedu-Addo
Employees
15
Headquarters
Princeton, New Jersey
Founded
2005
Market Cap
99.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
623.88K
High Today
$5.50
Low Today
$4.95
Open Price
$5.50
Volume
503.84K
52 Week High
$7.30
52 Week Low
$0.664
PDSB Earnings
-$1.10
-$0.73
-$0.37
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, Pre-Market